Ignite Creation Date:
2024-05-06 @ 3:46 AM
Last Modification Date:
2024-10-26 @ 11:38 AM
Study NCT ID:
NCT02367638
Status:
COMPLETED
Last Update Posted:
2017-04-27
First Post:
2015-02-12
Brief Title:
Dose-escalation Phase 1 to Evaluate the Safety and Efficacy of MG1111 in Healthy Adults
Sponsor:
Green Cross Corporation
Organization:
GC Biopharma Corp
Organization Data
Organization:
GC Biopharma Corp
Class:
INDUSTRY
Study ID:
MG1111_P1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Green Cross Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None